Short-term outcomes of proton vs photon radiation for IDH-mutated gliomas
Part of Cancer clinical trials.
This study looks at the short-term results of proton and photon radiation therapy in people with IDH-mutated grade 2 or 3 gliomas. It compares the two types of radiation to see how well they work and what side effects might occur.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed grade 2 or grade 3 glioma with an IDH mutation.
- You received radiation therapy between January 2018 and June 2022.
- After radiation, you also had chemotherapy (either PCV or temozolomide).
- You are 18 years or older.
- You have not had radiation to the brain before this treatment.
- You received the standard radiation dose (not a different schedule).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation therapy (proton beams vs. standard photon x-rays) for people with certain slow-growing brain tumors (gliomas) that have a specific gene change. The goal is to see which type better preserves thinking skills and quality of life while treating the tumor.
This trial tests a new type of proton radiation therapy given at a lower dose rate to treat brain tumors that have come back after previous radiation. The goal is to see if it's safe and effective.
This trial compares two types of radiation—proton therapy versus photon (standard) therapy—for adults with an IDH-mutated grade 2 or 3 brain tumor. The goal is to see which approach works better and/or causes fewer side effects while treating the tumor.
This trial compares two ways of giving radiation—standard photon radiotherapy (IMRT) versus proton beam therapy—for people with glioblastoma. It may help find a safer or more effective radiation approach for shrinking tumors and improving outcomes.
This study compares two types of radiation therapy for adults with primary brain tumors that have a good outlook (expected survival longer than 5 years). You will receive either standard photon radiation or the more targeted proton radiation, to see if one works better or causes fewer side effects.
This study compares two types of radiation—protons and photons (X-rays)—for specific brain tumors or tumor returns. It aims to see which approach works best and is safest for you, based on how much and where the radiation is delivered.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.